Multi-Location Customer Places Order of the Acarix CADScor System with Goal to Scale Usage
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the sale of 9 CADScor Systems and 500 sing...
Acarix resolves on a directed issue to the guarantors of the warrant series 3
Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...
Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Board member purchases shares in Acarix
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Dr. Tony Daz, Board member of Acarix, purchased 2,000,6...
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...
Nationally Recognized Cardiology Practice Places Multiunit Order of the Acarix CADScor System
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that Connected Cardiovascular Care Associa...
CEO purchases shares in Acarix
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Aamir Mahmood, President and CEO of Acarix, purchased 2...
FILTER-SCAD Study Results Demonstrate Need for Point of Care Rule-Out Options for Coronary Artery Disease in Low-Risk Patients
Malmö, Sweden — Acarix, a leader in advanced acoustic-based cardiac diagnostics, announced that the results of the FILTER-SC...
Acarix receives additional declaration of intent and fully secures the warrants of series TO 3 through guarantee agreements
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the Company has rec...
Acarix Secures Order with National Concierge Healthcare Organization
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces its first order of the CADScor System with a prominent ...
Acarix receives declarations of intent to exercise warrants of series TO 3
Acarix AB ("Acarix" or the "Company") has received declarations of intent to exercise Warrants of series TO 3 (the "Warrants") from a n...
Acarix Q2 2024 video presentation
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, held a live presentation of the second-quarter results today Thur...